** Shares of AI biologics firm Absci Corp ABSI.O rise 30.6% to $4.01 premarket
** Co announces a strategic collaboration with Advanced Micro Devices AMD.O, where the chipmaker will invest $20 mln in co to power AI drug discovery
** The investment is structured as a private investment in public equity or PIPE financing
** The partnership will provide AI solutions and also help reduce infrastructure costs for ABSI
** ABSI will deploy AMD's AI chips to help in drug discovery which "will enable us to further the development of next-generation antibody therapeutics"- ABSI
** Absci previously struck a deal worth up to $247 mln with drugmaker AstraZeneca AZN.L to design an antibody to fight cancer
** Up to last close, ABSI had fallen 8.6% in the past 12 months
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。